Pilot trial of the safety, tolerability, and retinoid levels of N-(4-hydroxyphenyl) retinamide in combination with tamoxifen in patients at high risk for developing invasive breast cancer.
Conley B, O'Shaughnessy J, Prindiville S, Lawrence J, Chow C, Jones E, Merino MJ, Kaiser-Kupfer MI, Caruso RC, Podgor M, Goldspiel B, Venzon D, Danforth D, Wu S, Noone M, Goldstein J, Cowan KH, Zujewski J.
Conley B, et al. Among authors: wu s.
J Clin Oncol. 2000 Jan;18(2):275-83. doi: 10.1200/JCO.2000.18.2.275.
J Clin Oncol. 2000.
PMID: 10637240
Clinical Trial.